Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
ANTAZERO X KRIS VAN ASSCHE Debuts Globally at Dover Street Market Paris
In the pop-up up at Dover Street Market Paris, the aesthetic language of ANTAZERO X KRIS VAN ASSCHE collection is seamlessly woven into the space, bringing in a restrained yet highly distinctive visual vision. Guests walk through a corridor dominated by deep black tones and encounter large-scale campaign visuals along the walls to feel the stylistic direction. The journey concludes in a minimalist space where visitors could experience the craftsmanship, materials, and the dialogue between sport…
PR Newswire
23/11/2025
Antlara Dental Introduces an AI assistant designed to help inform patients…
Spending hours upon hours poring over various search engine results pages is a thing of the past. Patients can ask the AI assistant anything they want about dental tourism to Turkey. Patients can also find comprehensive details regarding Antlara Dental's applications and services through the assistant. Spending hours upon hours poring over various search engine results pages is a thing of the past. Patients can ask theAI assistantanything they want about dental tourism toTurkey...
PR Newswire
21/11/2025
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper…
8th Annual Evercore Healthcare Conference Wednesday, December 3, 2025, at 8:20 A.M. Eastern Time (ET)Piper Sandler 37th Annual Healthcare Conference Wednesday, December 3, 2025, at 11:00 A.M. Eastern Time (ET)Citi’s 2025 Global Healthcare Conference Thursday, December 4, 2025, at 10:30 A.M. Eastern Time (ET) To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.An archived version of the...
Nasdaq GlobeNewswire
21/11/2025
Inventiva reports 2025 Third Quarter Financial Information¹
Cash and cash equivalents at €97.6 million, and €24.7 million in short-term deposits 2as of September 30, 2025.Revenues of €4.5 million for the first nine months of 2025.Cash runway expected until the end of the first quarter of 2027 3, including net proceeds from the November 2025 public offering.Daix (France), New York City, (New York, United States), November 21, 2025– Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage...
Nasdaq GlobeNewswire
21/11/2025
Healthcare Customer Relationship Management (CRM) Market Poised for Robust…
Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1052821 Download PDF Brochure: https://www.marketresearchintellect.com/download-sample/?rid=1052821 202 - Pages 126 – Tables 37 – Figures Scope Of The Report Healthcare Customer Relationship Management (CRM) Market Overview 1. Rising Need for Improved Patient Engagement The global Healthcare CRM market is expanding rapidly due to the increasing shift toward patient-centric...
PR Newswire
21/11/2025
Patient-Derived Xenograft/PDX Model Market worth US$0.66 billion by 2030 with…
Browse in-depth TOC on "PDX Model Market" Browse in-depth TOC on "PDX Model Market" 300 - Tables 50 - Figures 300 - Pages By type,the PDX model market is segmented into mouse models and rat models. The mouse model segment is expected to witness the highest growth rate during the forecast period, driven by its genetic similarity to humans, well-established immune-deficient strains, and proven reliability in replicating human tumor biology. Mouse PDX models provide high...
PR Newswire
21/11/2025
Prostate Cancer Drugs Market to Reach USD 28.10 Billion by 2033 | According to…
Download PDF Brochure: https://www.datamintelligence.com/download-sample/prostate-cancer-drugs-market Download PDF Brochure:https://www.datamintelligence.com/download-sample/prostate-cancer-drugs-market Browse in-depth TOC on "Prostate Cancer Drugs Market" 62 – Tables 57 – Figures 159 – Pages Market Outlook: Precision Oncology & Hormonal Innovation Continue to Reshape Global Demand Prostate cancer treatment has evolved significantly over the last decade...
PR Newswire
21/11/2025
From Vietnam to Italy to the Middle East: Better by MTA Expands Platinum Network…
Saudi German Health (MENA region) Saudi German Health (MENA region) Building on a long legacy as medical pioneers in the Kingdom, Saudi German Health was founded by the Batterjee family and has become one of the leading private healthcare providers across theMiddle EastandNorth Africa. Stretching across the MENA region, with a vast network of existing and upcoming hospitals and clinics acrossSaudi Arabia, UAE,Yemen,Egypt,MoroccoandPakistan, Saudi German Health is...
PR Newswire
21/11/2025
Blood Glucose Monitoring System Market worth US$25.4 billion by 2030 with 9.1%…
Browse in-depth TOC on "Blood Glucose Monitoring System Market" Browse in-depth TOC on "Blood Glucose Monitoring System Market" 250 - Tables 60 - Figures 310 - Pages By product type,the global blood glucose monitor market is divided into four main segments: self-monitoring blood glucose systems, continuous glucose monitoring systems, Professional Point of care devices, and noninvasive products. The self-monitoring blood glucose systems segment accounted for the largest...
PR Newswire
21/11/2025
OKYO Pharma Announces Chairman and Founder Acquires Shares
LONDON and NEW YORK, Nov.21, 2025(GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO ), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, today announces that Panetta Partners Limited, an entity in which Gabriele Cerrone, Executive Chairman has a beneficial interest, has acquired 82,018 of the...
Nasdaq GlobeNewswire
21/11/2025
Midea Demonstrates Comprehensive Sustainable HVAC Lineup at C&R 2025 in Madrid
Backed by a research force of over 10,000 engineers and 42 pilot laboratories, Midea has developed a full-spectrum R290 product matrix. These offerings span residential, commercial, and industrial applications, reflecting the company's strategic vision of making green technology scalable and accessible. Backed by a research force of over 10,000 engineers and 42 pilot laboratories, Midea has developed a full-spectrum R290 product matrix. These offerings span residential, commercial, and...
PR Newswire
21/11/2025
Meril Life Sciences Presents One-year Outcomes from the LANDMARK Randomized…
The trial also assessed an extended clinical efficacy endpoint (Freedom from all-cause mortality, all stroke, procedure- or valve-related hospitalization and QOL deterioration) reflecting sustained clinical benefit over time. These extended outcomes remained consistent across platforms, measured at 80.5% for Myval THV Series, 75.0% for Sapien THV Series, and 79.7% for Evolut THV Series. Importantly, the Myval THV series demonstrated the lowest incidence of moderate aortic regurgitation, recorded…
PR Newswire
21/11/2025
Trading by management and close relations of management
Please read the full announcement in PDF Attachment 2025_49_Trading_By_Management
Nasdaq GlobeNewswire
21/11/2025
IEI Secures TFDA QMS Approval and ISO 13485 Certification, Reinforcing…
Backed by TFDA Class II credentials, IEI is prioritizing CDMO partnerships in medical imaging peripherals, vital-sign monitoring, and endoscopy/OR integration—bringing compliant designs to clinical use faster. Backed by TFDA Class II credentials, IEI is prioritizing CDMO partnerships in medical imaging peripherals, vital-sign monitoring, and endoscopy/OR integration—bringing compliant designs to clinical use faster. IEI's Qidu (Chi-Du) campus delivers 38K PCBA units per month and38K...
PR Newswire
21/11/2025
DermRays Launches Care+, a New Enhanced Protection Program for At-Home Laser…
DermRays Care+: Total Protection for Your Device DermRays Care+: Total Protection for Your Device Extended Hardware Warranty - Adds an additional 1-year product warranty beyond the standard coverage. Accidental Damage Protection - Covers up to 2 accidental damage incidents, including drops or liquid exposure, throughout the warranty period. Accessory Coverage - Protects original in-box accessories against manufacturing defects. Priority Support Access - Provides direct access to...
PR Newswire
21/11/2025
Kanazawa University research: Scientists develop a new method to measure…
Experimental Approach Experimental Approach The team led bySatoshi Araidesigned qMaLioffG by carefully engineering a fluorescent protein that behaves differently depending on how much ATP is present (Figure 1). When ATP binds to this protein, the duration of its glow—known as fluorescence lifetime—changes in a measurable way. Unlike brightness, which can be influenced by microscope settings, protein concentration, or cell shape, fluorescence lifetime is unaffected by experimental...
PR Newswire
21/11/2025
Colebrook Bosson Saunders Launches Their First Sustainability Report
Amalie Aarestrup, Sustainability Lead, Colebrook Bosson Saunders, commented: "We [under MillerKnoll] are united by the same sustainability mission, yet each brand brings its own priorities and solutions. We're excited for the road ahead — harnessing innovation to keep moving toward a future of positive change." Amalie Aarestrup, Sustainability Lead, Colebrook Bosson Saunders, commented: "We [under MillerKnoll] are united by the same sustainability mission, yet each brand brings…
PR Newswire
21/11/2025
Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to…
Alcohol Use Disorder Market Summary Alcohol Use Disorder Market Summary Discover the new alcohol use disorder treatment @Alcohol Use Disorder Treatment Market Key Factors Driving the Growth of the Alcohol Use Disorder Market Rising Prevalence of Alcohol Use Disorder Increasing rates of alcohol consumption worldwide, coupled with lifestyle changes and stress-related factors, have led to a growing number of individuals diagnosed with AUD. The 12-month diagnosed prevalent...
PR Newswire
20/11/2025
Information on the total number of voting rights and shares
REGULATED INFORMATIONInformation on the total number of voting rights and sharesMont-Saint-Guibert(Belgium), November 20, 2025 , 10:30 pm CET / 4:30 pm ET –In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares. Share capital: EUR 6.504.688,76 Total number of securities carrying voting rights: 43,026,460 (all ordinary...
Nasdaq GlobeNewswire
20/11/2025
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen…
In the study, three rabbits and three Göttingen minipigs were administered a single injection of LPT-CBD at ascending doses. The animals were then evaluated for pharmacokinetics and preliminary safety parameters for a period of 10 days in rabbits and 28 days in minipigs. Key findings include: In the study, three rabbits and three Göttingen minipigs were administered a single injection of LPT-CBD at ascending doses. The animals were then evaluated for pharmacokinetics and preliminary safety...
PR Newswire
20/11/2025
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company AnnouncementCOPENHAGEN, Denmark; November 20, 2025 –Genmab A/S(Nasdaq: GMAB) announced today that the Board of Directors decided to grant 6,933 restricted stock units and 7,377 warrants to employees of the Company and the Company's subsidiaries. Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A/S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market...
Nasdaq GlobeNewswire
20/11/2025
Northwest Biotherapeutics Announces That Construction Activities Are Under Way…
When a medical product is able to be manufactured using closed equipment and procedures that are not open to the air, the manufacturing can be conducted in Grade C manufacturing suites which are much less onerous and expensive to operate. In addition, multiple or numerous patient products may be manufactured simultaneously in a single Grade C manufacturing, and only certain equipment (not the whole suite) must be cleaned between production batches. These differences can enable a major increase…
PR Newswire
20/11/2025
GENFIT Reports Third Quarter 2025 Financial Information and Provides a Corporate…
Cash and cash equivalents totaled €119.0 million as of September 30, 2025€39.2 million in revenues for the nine months ended September 30, 2025, including the €26.5 million milestone payment following pricing and reimbursement approval of Iqirvo ®(elafibranor) in three major European markets Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), November 20, 2025-GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving...
Nasdaq GlobeNewswire
20/11/2025
Oxurion Receives Transparency Notification from Atlas Special Opportunities II…
Leuven, BELGIUM – November 20, 2025 – 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation1 it has received a transparency notification as follows: Oxurion received a transparency notification on November 20, 2025, from Atlas Special Opportunities…
Actusnews Wire
20/11/2025
Altri Comunicati